Valneva

Valneva's reported carbon emissions

Valneva, a pharmaceutical preparation manufacturing company headquartered in France (FR), reported a total of approximately 59.3 million kg CO2e in emissions for 2024. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. In 2024, Scope 1 emissions were approximately 1.3 million kg CO2e, while Scope 2 emissions accounted for about 2.5 million kg CO2e. Scope 3 emissions were the largest component, totalling approximately 55.5 million kg CO2e, with purchased goods and services (approximately 35 million kg CO2e) and upstream transportation and distribution (approximately 9 million kg CO2e) being significant contributors. For 2023, Valneva reported a total of approximately 4.8 million kg CO2e. This included around 1.7 million kg CO2e for Scope 1, about 1.5 million kg CO2e for Scope 2, and approximately 1.6 million kg CO2e for Scope 3. Valneva has set a near-term target to reduce its CO2 emissions from laboratories and manufacturing sites by 50% from a 2022 baseline by 2030, covering both Scope 1 and Scope 2 emissions. As of 2023, the company achieved a 48% reduction in its own CO2 emissions (Scope 1 and 2) since 2019, which represented a reduction of approximately 1,630 tonnes of CO2 emissions from gas and electricity consumption. Valneva also reported a GHG intensity of 0.35 units of revenue per unit of emissions, based on data from its 2024 Sustainability Statement.